Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Buprenorphine 400microgram sublingual tablets sugar free |
| BNF code | 0407020B0AAADAD |
| Virtual Therapeutic Moiety | Buprenorphine |
| Date identifier became valid | 3 Jul 2023 |
| Previous product identifier | 322492007 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 6 Jan 2005 |
| Previous name | Buprenorphine 400microgram sublingual tablets |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✓ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Buprenorphine hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 387173000 |
| Strength value numerator | 400.000 |
| Strength value numerator unit | microgram |
| Ontology Drug Form & Route | |
| Form & Route | tabletsublingual.oromucosal |
| Dose Form | |
| Formulation | Sublingual tablet |
| Drug Route | |
| Route | Sublingual |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 3 (CD No Register) |
| Actual Medicinal Products | |
| Buprenorphine 400microgram sublingual tablets sugar free (A A H Pharmaceuticals Ltd) | |
| Buprenorphine 400microgram sublingual tablets sugar free (Accord-UK Ltd) | |
| Buprenorphine 400microgram sublingual tablets sugar free (Medihealth (Northern) Ltd) | |
| Buprenorphine 400microgram sublingual tablets sugar free (Morningside Healthcare Ltd) | |
| Buprenorphine 400microgram sublingual tablets sugar free (Phoenix Healthcare Distribution Ltd) | |
| Buprenorphine 400microgram sublingual tablets sugar free (Sigma Pharmaceuticals Plc) | |
| Prefibin 0.4mg sublingual tablets (Sandoz Ltd) | |
| Subutex 0.4mg sublingual tablets (Indivior UK Ltd) | |
| Temgesic 400microgram sublingual tablets (Eumedica Pharma Ltd) | |
| Tephine 400microgram sublingual tablets (Sandoz Ltd) | |
| Virtual Medicinal Product Packs | |
| Buprenorphine 400microgram sublingual tablets sugar free 50 tablet | |
| Buprenorphine 400microgram sublingual tablets sugar free 7 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_12.0.0_20251201000001, imported on 2nd December 2025 at 05:00:34.